skip to main content

H.R. 2855 (116th): To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

Call or Write Congress

Sponsor and status

Steve King

Sponsor. Representative for Iowa's 4th congressional district. Republican.

Read Text »
Last Updated: May 20, 2019
Length: 2 pages
May 20, 2019
116th Congress (2019–2021)
Died in a previous Congress

This bill was introduced on May 20, 2019, in a previous session of Congress, but it did not receive a vote.


Position statements

What legislators are saying

Kings Special Guest for President Trumps State of the Union Address: Jason Harrington, President and CEO of Lakes Regional Healthcare
    — Rep. Steve King [R-IA4, 2013-2020] (Sponsor) on Feb 4, 2020

King Honors Jaci Hermstad on the House Floor
    — Rep. Steve King [R-IA4, 2013-2020] (Sponsor) on Jun 25, 2019

King Welcomes FDAs Decision to Expedite Jaci Hermstads Treatment
    — Rep. Steve King [R-IA4, 2013-2020] (Sponsor) on May 24, 2019

More statements at ProPublica Represent...


May 20, 2019

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

H.R. 2855 (116th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 2855. This is the one from the 116th Congress.

This bill was introduced in the 116th Congress, which met from Jan 3, 2019 to Jan 3, 2021. Legislation not enacted by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2855 — 116th Congress: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for ...” 2019. January 19, 2021 <>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from, the official portal of the United States Congress. is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.